Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxart, Inc

0.4754
+0.00561.19%
Volume:112.36K
Turnover:53.79K
Market Cap:108.14M
PE:-1.19
High:0.4848
Open:0.4790
Low:0.4750
Close:0.4698
Loading ...

Vaxart Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
2 hours ago

Vaxart announces norovirus vaccine candidate trial data published

TIPRANKS
·
06 Mar

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

GlobeNewswire
·
06 Mar

Vaxart Inc - Project Agreement Stop Work Order in Effect for 90 Days

THOMSON REUTERS
·
24 Feb

Vaxart - on Feb 21, Received Stop Work Orders From Advanced Technology International for Project Agreement No. 01

THOMSON REUTERS
·
24 Feb

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

THOMSON REUTERS
·
28 Jan

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

GlobeNewswire
·
28 Jan

Oppenheimer Sticks to Their Buy Rating for Vaxart (VXRT)

TIPRANKS
·
14 Jan

Vaxart Says Oral Covid-19 Vaccine Candidate Recommended for Continued Study

MT Newswires Live
·
14 Jan

Vaxart Announces Favorable Dsmb Review of Sentinel Cohort From Covid-19 Phase 2B Clinical Trial

THOMSON REUTERS
·
14 Jan

Sector Update: Health Care Stocks Lower in Late Afternoon Trading

MT Newswires Live
·
28 Dec 2024

Top Midday Gainers

MT Newswires Live
·
28 Dec 2024

Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study

MT Newswires Live
·
28 Dec 2024

Vaxart project agreement change ups funding for oral COVID vaccine candidate

TIPRANKS
·
27 Dec 2024

Vaxart - Funding Ceiling Increased to About $460.7 Million; Funding for Trial Increased to About $134.2 Million

THOMSON REUTERS
·
27 Dec 2024

Vaxart Inc - Enters Into Modification No. 4 to Project Agreement With Advanced Technology International

THOMSON REUTERS
·
27 Dec 2024